10-K/A: Annual report (Amendment)
Apr 25 00:47
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WRIGHT TIMOTHY R
Apr 2 09:43
Protagenic Therapeutics | 10-K: Annual report
Apr 2 04:03
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stein Robert Benjamin
Mar 30 09:33
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrage Khalil
Mar 30 09:33
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Buell Jennifer
Mar 30 09:33
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ARMEN GARO H
Mar 30 09:33
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian
Mar 30 09:33
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arrow Alexander K.
Mar 30 09:33
Protagenic Therapeutics | 8-K: Current report
Mar 21 20:56
Protagenic Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.13%),Steven Boyd(5.13%)
Feb 15 04:28
Protagenic Therapeutics | 8-K: Current report
Dec 16, 2023 04:50
Protagenic Therapeutics | 8-K: Current report
Nov 30, 2023 06:18
Protagenic Therapeutics: Q3 2023 Earnings Report
Nov 15, 2023 05:02
Protagenic Therapeutics | DEF 14A: Definitive information statements
Nov 3, 2023 04:29
Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Arrow Alexander K.
Oct 14, 2023 00:48
Protagenic Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 15, 2023 03:29
Protagenic Therapeutics | 10-Q: Q1 2023 Earnings Report
May 16, 2023 02:23
Protagenic Therapeutics | 10-K/A: Annual report (Amendment)
Apr 18, 2023 02:43
Protagenic Therapeutics: FY2022 Annual Report
10-K | Protagenic Therapeutics, Inc.\new (0001022899) (Filer)
Apr 1, 2023 03:03
No Data
No Data